Global Pharmaceutical CDMO Solution Market Research Report 2023

Pharmaceutical CDMO Solution Market

Pharmaceutical CDMO (Contract Development and Manufacturing Organization) solutions refer to the services offered by companies that provide end-to-end outsourcing services to the pharmaceutical industry. CDMOs partner with pharmaceutical companies to assist in various stages of drug development, from early-stage research and development (R&D) to commercial-scale manufacturing and distribution.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical CDMO Solution market research.

The pharmaceutical Contract Development and Manufacturing Organization (CDMO) industry has experienced significant growth and transformation in recent years. CDMOs play a crucial role in supporting pharmaceutical companies by providing a wide range of services to expedite drug development and manufacturing processes. Pharmaceutical companies increasingly rely on CDMOs to access specialized expertise, advanced technologies, and cost-effective solutions, enabling them to focus on core research and marketing activities. The rising complexity of drug development, along with increasing regulatory requirements, has led to a higher demand for CDMO services, particularly in specialized areas like biologics, gene therapies, and personalized medicine. The United States and Canada are significant markets for pharmaceutical CDMOs due to a large number of biopharmaceutical companies and a robust outsourcing landscape. European countries, including the United Kingdom, Germany, and Switzerland, have a well-established pharmaceutical industry, contributing to a strong demand for CDMO services. Countries like India, China, and South Korea have emerged as major players in the CDMO market, offering cost-competitive services and advanced manufacturing capabilities. The global market for pharmaceutical CDMO solutions is expected to witness continued growth in the coming years, driven by increased outsourcing by pharmaceutical companies seeking specialized expertise, cost-effectiveness, and accelerated drug development timelines. Additionally, the ongoing advancements in biotechnology, gene therapies, and personalized medicine are likely to create new opportunities for CDMOs, as these cutting-edge areas require specialized capabilities and infrastructure.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical CDMO Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Pharmaceutical CDMO Solution Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Active Pharmaceutical Ingredient (API) Manufacturing

1.2.3 Finished Dosage Formulation (FDF) Development and Manufacturing

1.2.4 Secondary Packaging

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pharmaceutical CDMO Solution Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pharmaceutical CDMO Solution Market Perspective (2018-2029)

2.2 Pharmaceutical CDMO Solution Growth Trends by Region

2.2.1 Global Pharmaceutical CDMO Solution Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pharmaceutical CDMO Solution Historic Market Size by Region (2018-2023)

2.2.3 Pharmaceutical CDMO Solution Forecasted Market Size by Region (2024-2029)

2.3 Pharmaceutical CDMO Solution Market Dynamics

2.3.1 Pharmaceutical CDMO Solution Industry Trends

2.3.2 Pharmaceutical CDMO Solution Market Drivers

2.3.3 Pharmaceutical CDMO Solution Market Challenges

2.3.4 Pharmaceutical CDMO Solution Market Restraints

3.1 Global Top Pharmaceutical CDMO Solution Players by Revenue

3.1.1 Global Top Pharmaceutical CDMO Solution Players by Revenue (2018-2023)

3.1.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Players (2018-2023)

3.2 Global Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmaceutical CDMO Solution Revenue

3.4 Global Pharmaceutical CDMO Solution Market Concentration Ratio

3.4.1 Global Pharmaceutical CDMO Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Solution Revenue in 2022

3.5 Pharmaceutical CDMO Solution Key Players Head office and Area Served

3.6 Key Players Pharmaceutical CDMO Solution Product Solution and Service

3.7 Date of Enter into Pharmaceutical CDMO Solution Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pharmaceutical CDMO Solution Historic Market Size by Type (2018-2023)

4.2 Global Pharmaceutical CDMO Solution Forecasted Market Size by Type (2024-2029)

5.1 Global Pharmaceutical CDMO Solution Historic Market Size by Application (2018-2023)

5.2 Global Pharmaceutical CDMO Solution Forecasted Market Size by Application (2024-2029)

6.1 North America Pharmaceutical CDMO Solution Market Size (2018-2029)

6.2 North America Pharmaceutical CDMO Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pharmaceutical CDMO Solution Market Size by Country (2018-2023)

6.4 North America Pharmaceutical CDMO Solution Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pharmaceutical CDMO Solution Market Size (2018-2029)

7.2 Europe Pharmaceutical CDMO Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pharmaceutical CDMO Solution Market Size by Country (2018-2023)

7.4 Europe Pharmaceutical CDMO Solution Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pharmaceutical CDMO Solution Market Size (2018-2029)

8.2 Asia-Pacific Pharmaceutical CDMO Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2018-2023)

8.4 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pharmaceutical CDMO Solution Market Size (2018-2029)

9.2 Latin America Pharmaceutical CDMO Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pharmaceutical CDMO Solution Market Size by Country (2018-2023)

9.4 Latin America Pharmaceutical CDMO Solution Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pharmaceutical CDMO Solution Market Size (2018-2029)

10.2 Middle East & Africa Pharmaceutical CDMO Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2018-2023)

10.4 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Recipharm AB

11.1.1 Recipharm AB Company Detail

11.1.2 Recipharm AB Business Overview

11.1.3 Recipharm AB Pharmaceutical CDMO Solution Introduction

11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.1.5 Recipharm AB Recent Development

11.2 Lonza Group

11.2.1 Lonza Group Company Detail

11.2.2 Lonza Group Business Overview

11.2.3 Lonza Group Pharmaceutical CDMO Solution Introduction

11.2.4 Lonza Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.2.5 Lonza Group Recent Development

11.3 Catalent

11.3.1 Catalent Company Detail

11.3.2 Catalent Business Overview

11.3.3 Catalent Pharmaceutical CDMO Solution Introduction

11.3.4 Catalent Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.3.5 Catalent Recent Development

11.4 Patheon (Thermo Fisher Scientific)

11.4.1 Patheon (Thermo Fisher Scientific) Company Detail

11.4.2 Patheon (Thermo Fisher Scientific) Business Overview

11.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Introduction

11.4.4 Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.4.5 Patheon (Thermo Fisher Scientific) Recent Development

11.5 Siegfried AG

11.5.1 Siegfried AG Company Detail

11.5.2 Siegfried AG Business Overview

11.5.3 Siegfried AG Pharmaceutical CDMO Solution Introduction

11.5.4 Siegfried AG Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.5.5 Siegfried AG Recent Development

11.6 SGS Quay Pharmaceuticals

11.6.1 SGS Quay Pharmaceuticals Company Detail

11.6.2 SGS Quay Pharmaceuticals Business Overview

11.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Introduction

11.6.4 SGS Quay Pharmaceuticals Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.6.5 SGS Quay Pharmaceuticals Recent Development

11.7 Curia

11.7.1 Curia Company Detail

11.7.2 Curia Business Overview

11.7.3 Curia Pharmaceutical CDMO Solution Introduction

11.7.4 Curia Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.7.5 Curia Recent Development

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Detail

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific Pharmaceutical CDMO Solution Introduction

11.8.4 Thermo Fisher Scientific Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.8.5 Thermo Fisher Scientific Recent Development

11.9 Samsung Biologics

11.9.1 Samsung Biologics Company Detail

11.9.2 Samsung Biologics Business Overview

11.9.3 Samsung Biologics Pharmaceutical CDMO Solution Introduction

11.9.4 Samsung Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.9.5 Samsung Biologics Recent Development

11.10 Fujifilm Diosynth Biotechnologies

11.10.1 Fujifilm Diosynth Biotechnologies Company Detail

11.10.2 Fujifilm Diosynth Biotechnologies Business Overview

11.10.3 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Introduction

11.10.4 Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.10.5 Fujifilm Diosynth Biotechnologies Recent Development

11.11 Societal CDMO

11.11.1 Societal CDMO Company Detail

11.11.2 Societal CDMO Business Overview

11.11.3 Societal CDMO Pharmaceutical CDMO Solution Introduction

11.11.4 Societal CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.11.5 Societal CDMO Recent Development

11.12 Aenova Group

11.12.1 Aenova Group Company Detail

11.12.2 Aenova Group Business Overview

11.12.3 Aenova Group Pharmaceutical CDMO Solution Introduction

11.12.4 Aenova Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.12.5 Aenova Group Recent Development

11.13 Eurofins CDMO

11.13.1 Eurofins CDMO Company Detail

11.13.2 Eurofins CDMO Business Overview

11.13.3 Eurofins CDMO Pharmaceutical CDMO Solution Introduction

11.13.4 Eurofins CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.13.5 Eurofins CDMO Recent Development

11.14 Piramal Group

11.14.1 Piramal Group Company Detail

11.14.2 Piramal Group Business Overview

11.14.3 Piramal Group Pharmaceutical CDMO Solution Introduction

11.14.4 Piramal Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.14.5 Piramal Group Recent Development

11.15 WuXi AppTec Group

11.15.1 WuXi AppTec Group Company Detail

11.15.2 WuXi AppTec Group Business Overview

11.15.3 WuXi AppTec Group Pharmaceutical CDMO Solution Introduction

11.15.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.15.5 WuXi AppTec Group Recent Development

11.16 Fareva

11.16.1 Fareva Company Detail

11.16.2 Fareva Business Overview

11.16.3 Fareva Pharmaceutical CDMO Solution Introduction

11.16.4 Fareva Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.16.5 Fareva Recent Development

11.17 Strides Pharma Science

11.17.1 Strides Pharma Science Company Detail

11.17.2 Strides Pharma Science Business Overview

11.17.3 Strides Pharma Science Pharmaceutical CDMO Solution Introduction

11.17.4 Strides Pharma Science Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.17.5 Strides Pharma Science Recent Development

11.18 Famar Health Care Service

11.18.1 Famar Health Care Service Company Detail

11.18.2 Famar Health Care Service Business Overview

11.18.3 Famar Health Care Service Pharmaceutical CDMO Solution Introduction

11.18.4 Famar Health Care Service Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.18.5 Famar Health Care Service Recent Development

11.19 WuXi Biologics

11.19.1 WuXi Biologics Company Detail

11.19.2 WuXi Biologics Business Overview

11.19.3 WuXi Biologics Pharmaceutical CDMO Solution Introduction

11.19.4 WuXi Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.19.5 WuXi Biologics Recent Development

11.20 Asymchem

11.20.1 Asymchem Company Detail

11.20.2 Asymchem Business Overview

11.20.3 Asymchem Pharmaceutical CDMO Solution Introduction

11.20.4 Asymchem Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.20.5 Asymchem Recent Development

11.21 Pfizer CentreOne

11.21.1 Pfizer CentreOne Company Detail

11.21.2 Pfizer CentreOne Business Overview

11.21.3 Pfizer CentreOne Pharmaceutical CDMO Solution Introduction

11.21.4 Pfizer CentreOne Revenue in Pharmaceutical CDMO Solution Business (2018-2023)

11.21.5 Pfizer CentreOne Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Active Pharmaceutical Ingredient (API) Manufacturing

    Table 3. Key Players of Finished Dosage Formulation (FDF) Development and Manufacturing

    Table 4. Key Players of Secondary Packaging

    Table 5. Key Players of Others

    Table 6. Global Pharmaceutical CDMO Solution Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Pharmaceutical CDMO Solution Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Pharmaceutical CDMO Solution Market Share by Region (2018-2023)

    Table 10. Global Pharmaceutical CDMO Solution Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Pharmaceutical CDMO Solution Market Share by Region (2024-2029)

    Table 12. Pharmaceutical CDMO Solution Market Trends

    Table 13. Pharmaceutical CDMO Solution Market Drivers

    Table 14. Pharmaceutical CDMO Solution Market Challenges

    Table 15. Pharmaceutical CDMO Solution Market Restraints

    Table 16. Global Pharmaceutical CDMO Solution Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Pharmaceutical CDMO Solution Market Share by Players (2018-2023)

    Table 18. Global Top Pharmaceutical CDMO Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2022)

    Table 19. Ranking of Global Top Pharmaceutical CDMO Solution Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Pharmaceutical CDMO Solution Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Pharmaceutical CDMO Solution Product Solution and Service

    Table 23. Date of Enter into Pharmaceutical CDMO Solution Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Pharmaceutical CDMO Solution Revenue Market Share by Type (2018-2023)

    Table 27. Global Pharmaceutical CDMO Solution Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Pharmaceutical CDMO Solution Revenue Market Share by Type (2024-2029)

    Table 29. Global Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Pharmaceutical CDMO Solution Revenue Market Share by Application (2018-2023)

    Table 31. Global Pharmaceutical CDMO Solution Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Pharmaceutical CDMO Solution Revenue Market Share by Application (2024-2029)

    Table 33. North America Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Pharmaceutical CDMO Solution Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Pharmaceutical CDMO Solution Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Pharmaceutical CDMO Solution Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Pharmaceutical CDMO Solution Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Pharmaceutical CDMO Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Recipharm AB Company Detail

    Table 49. Recipharm AB Business Overview

    Table 50. Recipharm AB Pharmaceutical CDMO Solution Product

    Table 51. Recipharm AB Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 52. Recipharm AB Recent Development

    Table 53. Lonza Group Company Detail

    Table 54. Lonza Group Business Overview

    Table 55. Lonza Group Pharmaceutical CDMO Solution Product

    Table 56. Lonza Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 57. Lonza Group Recent Development

    Table 58. Catalent Company Detail

    Table 59. Catalent Business Overview

    Table 60. Catalent Pharmaceutical CDMO Solution Product

    Table 61. Catalent Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 62. Catalent Recent Development

    Table 63. Patheon (Thermo Fisher Scientific) Company Detail

    Table 64. Patheon (Thermo Fisher Scientific) Business Overview

    Table 65. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product

    Table 66. Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 67. Patheon (Thermo Fisher Scientific) Recent Development

    Table 68. Siegfried AG Company Detail

    Table 69. Siegfried AG Business Overview

    Table 70. Siegfried AG Pharmaceutical CDMO Solution Product

    Table 71. Siegfried AG Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 72. Siegfried AG Recent Development

    Table 73. SGS Quay Pharmaceuticals Company Detail

    Table 74. SGS Quay Pharmaceuticals Business Overview

    Table 75. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product

    Table 76. SGS Quay Pharmaceuticals Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 77. SGS Quay Pharmaceuticals Recent Development

    Table 78. Curia Company Detail

    Table 79. Curia Business Overview

    Table 80. Curia Pharmaceutical CDMO Solution Product

    Table 81. Curia Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 82. Curia Recent Development

    Table 83. Thermo Fisher Scientific Company Detail

    Table 84. Thermo Fisher Scientific Business Overview

    Table 85. Thermo Fisher Scientific Pharmaceutical CDMO Solution Product

    Table 86. Thermo Fisher Scientific Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 87. Thermo Fisher Scientific Recent Development

    Table 88. Samsung Biologics Company Detail

    Table 89. Samsung Biologics Business Overview

    Table 90. Samsung Biologics Pharmaceutical CDMO Solution Product

    Table 91. Samsung Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 92. Samsung Biologics Recent Development

    Table 93. Fujifilm Diosynth Biotechnologies Company Detail

    Table 94. Fujifilm Diosynth Biotechnologies Business Overview

    Table 95. Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product

    Table 96. Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 97. Fujifilm Diosynth Biotechnologies Recent Development

    Table 98. Societal CDMO Company Detail

    Table 99. Societal CDMO Business Overview

    Table 100. Societal CDMO Pharmaceutical CDMO Solution Product

    Table 101. Societal CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 102. Societal CDMO Recent Development

    Table 103. Aenova Group Company Detail

    Table 104. Aenova Group Business Overview

    Table 105. Aenova Group Pharmaceutical CDMO Solution Product

    Table 106. Aenova Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 107. Aenova Group Recent Development

    Table 108. Eurofins CDMO Company Detail

    Table 109. Eurofins CDMO Business Overview

    Table 110. Eurofins CDMO Pharmaceutical CDMO Solution Product

    Table 111. Eurofins CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 112. Eurofins CDMO Recent Development

    Table 113. Piramal Group Company Detail

    Table 114. Piramal Group Business Overview

    Table 115. Piramal Group Pharmaceutical CDMO Solution Product

    Table 116. Piramal Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 117. Piramal Group Recent Development

    Table 118. WuXi AppTec Group Company Detail

    Table 119. WuXi AppTec Group Business Overview

    Table 120. WuXi AppTec Group Pharmaceutical CDMO Solution Product

    Table 121. WuXi AppTec Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 122. WuXi AppTec Group Recent Development

    Table 123. Fareva Company Detail

    Table 124. Fareva Business Overview

    Table 125. Fareva Pharmaceutical CDMO Solution Product

    Table 126. Fareva Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 127. Fareva Recent Development

    Table 128. Strides Pharma Science Company Detail

    Table 129. Strides Pharma Science Business Overview

    Table 130. Strides Pharma Science Pharmaceutical CDMO Solution Product

    Table 131. Strides Pharma Science Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 132. Strides Pharma Science Recent Development

    Table 133. Famar Health Care Service Company Detail

    Table 134. Famar Health Care Service Business Overview

    Table 135. Famar Health Care Service Pharmaceutical CDMO Solution Product

    Table 136. Famar Health Care Service Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 137. Famar Health Care Service Recent Development

    Table 138. WuXi Biologics Company Detail

    Table 139. WuXi Biologics Business Overview

    Table 140. WuXi Biologics Pharmaceutical CDMO Solution Product

    Table 141. WuXi Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 142. WuXi Biologics Recent Development

    Table 143. Asymchem Company Detail

    Table 144. Asymchem Business Overview

    Table 145. Asymchem Pharmaceutical CDMO Solution Product

    Table 146. Asymchem Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 147. Asymchem Recent Development

    Table 148. Pfizer CentreOne Company Detail

    Table 149. Pfizer CentreOne Business Overview

    Table 150. Pfizer CentreOne Pharmaceutical CDMO Solution Product

    Table 151. Pfizer CentreOne Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)

    Table 152. Pfizer CentreOne Recent Development

    Table 153. Research Programs/Design for This Report

    Table 154. Key Data Information from Secondary Sources

    Table 155. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pharmaceutical CDMO Solution Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Pharmaceutical CDMO Solution Market Share by Type: 2022 VS 2029

    Figure 3. Active Pharmaceutical Ingredient (API) Manufacturing Features

    Figure 4. Finished Dosage Formulation (FDF) Development and Manufacturing Features

    Figure 5. Secondary Packaging Features

    Figure 6. Others Features

    Figure 7. Global Pharmaceutical CDMO Solution Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Pharmaceutical CDMO Solution Market Share by Application: 2022 VS 2029

    Figure 9. Pharmaceutical Company Case Studies

    Figure 10. Biotechnology Company Case Studies

    Figure 11. Others Case Studies

    Figure 12. Pharmaceutical CDMO Solution Report Years Considered

    Figure 13. Global Pharmaceutical CDMO Solution Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Pharmaceutical CDMO Solution Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Pharmaceutical CDMO Solution Market Share by Region: 2022 VS 2029

    Figure 16. Global Pharmaceutical CDMO Solution Market Share by Players in 2022

    Figure 17. Global Top Pharmaceutical CDMO Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Solution Revenue in 2022

    Figure 19. North America Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Pharmaceutical CDMO Solution Market Share by Country (2018-2029)

    Figure 21. United States Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Pharmaceutical CDMO Solution Market Share by Country (2018-2029)

    Figure 25. Germany Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Pharmaceutical CDMO Solution Market Share by Region (2018-2029)

    Figure 33. China Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Pharmaceutical CDMO Solution Market Share by Country (2018-2029)

    Figure 41. Mexico Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Pharmaceutical CDMO Solution Market Share by Country (2018-2029)

    Figure 45. Turkey Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 48. Lonza Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 49. Catalent Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 50. Patheon (Thermo Fisher Scientific) Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 51. Siegfried AG Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 52. SGS Quay Pharmaceuticals Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 53. Curia Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 55. Samsung Biologics Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 56. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 57. Societal CDMO Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 58. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 59. Eurofins CDMO Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 60. Piramal Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 61. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 62. Fareva Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 63. Strides Pharma Science Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 64. Famar Health Care Service Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 65. WuXi Biologics Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 66. Asymchem Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 67. Pfizer CentreOne Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed